Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis

Blood Pressure Monitoring

Volumn 20, Issue 2, 2015, Pages 57-63

  Cuspidi, Cesare ^a,b   Sala, Carla ^b   Tadic, Marijana ^d   Rescaldani, Marta ^b   Grassi, Guido ^a,c   Mancia, Giuseppe ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d Surgical Clinic   (Serbia)

Author keywords

ambulatory blood pressure monitoring; carotid intima media thickness; white coat hypertension

Indexed keywords

ARTERIAL WALL THICKNESS; BLOOD VESSEL INJURY; CAROTID ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; ADULT; CAROTID ARTERY DISEASES; COMPLICATION; FEMALE; MALE; PATHOPHYSIOLOGY;

ADULT; CAROTID ARTERY DISEASES; FEMALE; HUMANS; MALE; RISK FACTORS; WHITE COAT HYPERTENSION;

EID: 84925859495     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000094     Document Type: Review

References (41)

1. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension?. JAMA 1988; 259: 225-228
2. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999; 34: 267-272
3. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2: 695-698
4. Niiranen TJ, Jula AM, Kantola IM, Reunanen A. Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study. J Hypertens 2006; 24: 463-470
5. Cuspidi C, Parati G. Isolated clinic hypertension in a general population. J Hypertens 2006; 24: 437-440
6. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-Analysis. Clin J Am Soc Nephrol 2009; 4: 656-664
7. Cardillo C, de Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993; 21 (Pt 1): 836-844
8. Björklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation 2002; 106: 63-68
9. Landray MJ, Sagar G, Murray S, Beevers M, Beevers DG, Lip GY.White coat hypertension and carotid atherosclerosis. Blood Press 1999; 8: 134-140
10. Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M, Pauletto P. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 2008; 51: 1300-1305
11. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, Pessina AC. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31: 57-63
12. Mancia G. White coat effect. Innocuous or adverse phenomenon?. Eur Heart J 2000; 21: 1647-1648
13. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98: 1892-1897
14. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-Analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012; 59: 564-571
15. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2011; 24: 52-58
16. Gustavsen PH, Høegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 2003; 17: 811-817
17. Pierdomenico SD, Lapenna D, Bucci A, di Iorio A, Neri M, Cuccurullo F, Mezzetti A. Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension. Am J Hypertens 2004; 17: 876-881
18. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16: 949-961
19. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, et al. European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-Term trial. Circulation 2002; 106: 2422-2427
20. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494
21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-Artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22
22. Hald EM, Lijfering WM, Mathiesen EB, Johnsen SH, Løchen ML, Njølstad I, et al. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol 2014; 34: 226-230
23. Ziegelbauer K, Schaefer C, Steinmetz H, Sitzer M, Lorenz MW. Clinical usefulness of carotid ultrasound to improve stroke risk assessment: ten-year results from the Carotid Atherosclerosis Progression Study (CAPS). Eur J Prev Cardiol 2013; 20: 837-843
24. Nair SB, Malik R, Khattar RS. Carotid intima-media thickness: ultrasound measurement, prognostic value and role in clinical practice. Postgrad Med J 2012; 88: 694-699
25. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?. Hypertension 1995; 26: 413-419
26. Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension. J Hypertens 1995; 13 (Pt 2): 1707-1711
27. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, Mezzetti A. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26: 801-807
28. Zakopoulos N, Papamichael C, Papaconstantinou H, Dubbins PA, Burrell CJ, Lekakis J, et al. Isolated clinic hypertension is not an innocent phenomenon: effect on the carotid artery structure. Am J Hypertens 1999; 12: 245-250
29. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, Manuck SB. White-coat hypertension and carotid artery atherosclerosis: a matching study. Arch Intern Med 2000; 160: 1507-1512
30. Karter Y, Curgunlu A, Altnisik S, Erturk N, Vehid S, Mihmani I, et al. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent?. Blood Press 2003; 12 (5-6): 307-313
31. Nakashima T, Yamano S, Sasaki R, Minami S, Doi K, Yamamoto J, et al. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res 2004; 27: 739-745
32. Cuspidi C, Meani S, Sala C, Valerio C, Fusi V, Zanchetti A, Mancia G. How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring?. J Hypertens 2007; 25: 315-320
33. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. Target organ damage in 'white coat hypertension' and 'masked hypertension'. Am J Hypertens 2008; 21: 393-399
34. Sung SH, Cheng HM, Wang KL, Yu WC, Chuang SY, Ting CT, et al. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension 2013; 61: 1346-1353
35. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-Term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47: 846-853
36. Tunçkale A, Aran SN, Karpuz H, Dirican A. Relationship between insulin resistance and end-organ damage in white coat hypertension. Am J Hypertens 2004; 17 (Pt 1): 1011-1016
37. Hara A, Ohkubo T, Kikuya M, Shintani Y, Obara T, Metoki H, et al. Detection of carotid atherosclerosis in individuals with masked hypertension and whitecoat hypertension by self-measured blood pressure at home: the Ohasama study. J Hypertens 2007; 25: 321-327
38. Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, et al. Whitecoat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study. Stroke 2013; 44: 1512-1517
39. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-Term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54: 226-232
40. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, de Venuto G, et al. White-coat hypertension: a selection bias?. Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study. J Hypertens 1998; 16: 977-984
41. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357